| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | procollagen glucosyltransferase activity | 8.35e-05 | 3 | 106 | 2 | GO:0033823 | |
| GeneOntologyMolecularFunction | procollagen-lysine 5-dioxygenase activity | 8.35e-05 | 3 | 106 | 2 | GO:0008475 | |
| GeneOntologyMolecularFunction | protein serine/threonine/tyrosine kinase activity | 1.12e-04 | 47 | 106 | 4 | GO:0004712 | |
| GeneOntologyMolecularFunction | peptidyl-lysine 5-dioxygenase activity | 1.66e-04 | 4 | 106 | 2 | GO:0070815 | |
| GeneOntologyMolecularFunction | transporter activity | SLC9A9 ABCA12 ABCA13 ATP8A2 SLC6A17 HTR3E APOF ANO10 SLC15A3 SLCO1B1 SLC66A1 RYR2 SLC12A2 PKD1 TMC8 SLC4A10 TMEM109 | 4.33e-04 | 1289 | 106 | 17 | GO:0005215 |
| GeneOntologyMolecularFunction | lipid transporter activity | 6.27e-04 | 196 | 106 | 6 | GO:0005319 | |
| GeneOntologyBiologicalProcess | hydroxylysine biosynthetic process | 2.87e-05 | 2 | 111 | 2 | GO:0046947 | |
| GeneOntologyBiologicalProcess | hydroxylysine metabolic process | 2.87e-05 | 2 | 111 | 2 | GO:0046946 | |
| Domain | LRR_8 | 6.09e-07 | 171 | 107 | 9 | PF13855 | |
| Domain | Leu-rich_rpt_typical-subtyp | 8.13e-07 | 177 | 107 | 9 | IPR003591 | |
| Domain | LRR_TYP | 8.13e-07 | 177 | 107 | 9 | SM00369 | |
| Domain | Cys-rich_flank_reg_C | 8.40e-07 | 90 | 107 | 7 | IPR000483 | |
| Domain | LRRCT | 8.40e-07 | 90 | 107 | 7 | SM00082 | |
| Domain | Laminin_G | 2.02e-05 | 58 | 107 | 5 | IPR001791 | |
| Domain | Leu-rich_rpt | 2.59e-05 | 271 | 107 | 9 | IPR001611 | |
| Domain | LRR_1 | 3.79e-05 | 219 | 107 | 8 | PF00560 | |
| Domain | - | 9.59e-05 | 321 | 107 | 9 | 3.80.10.10 | |
| Domain | LYS_HYDROXYLASE | 9.72e-05 | 3 | 107 | 2 | PS01325 | |
| Domain | Procol_lys_dOase | 9.72e-05 | 3 | 107 | 2 | IPR001006 | |
| Domain | L_dom-like | 1.13e-04 | 328 | 107 | 9 | IPR032675 | |
| Domain | LamG | 1.16e-04 | 44 | 107 | 4 | SM00282 | |
| Domain | LRR | 1.58e-04 | 201 | 107 | 7 | PS51450 | |
| Domain | LRRNT | 2.50e-04 | 98 | 107 | 5 | IPR000372 | |
| Domain | LRRNT | 2.50e-04 | 98 | 107 | 5 | SM00013 | |
| Domain | ConA-like_dom | 2.68e-04 | 219 | 107 | 7 | IPR013320 | |
| Domain | fn3 | 3.41e-04 | 162 | 107 | 6 | PF00041 | |
| Domain | FN3 | 6.88e-04 | 185 | 107 | 6 | SM00060 | |
| Domain | LRRCT | 8.03e-04 | 32 | 107 | 3 | PF01463 | |
| Domain | FN3 | 1.01e-03 | 199 | 107 | 6 | PS50853 | |
| Domain | FN3_dom | 1.29e-03 | 209 | 107 | 6 | IPR003961 | |
| Domain | LAM_G_DOMAIN | 1.33e-03 | 38 | 107 | 3 | PS50025 | |
| Domain | Laminin_G_2 | 1.55e-03 | 40 | 107 | 3 | PF02210 | |
| Domain | ABC_A | 2.07e-03 | 12 | 107 | 2 | IPR026082 | |
| Domain | - | 2.17e-03 | 95 | 107 | 4 | 2.60.120.200 | |
| Domain | ARM-type_fold | 3.38e-03 | 339 | 107 | 7 | IPR016024 | |
| Domain | P4Hc | 3.70e-03 | 16 | 107 | 2 | SM00702 | |
| Domain | Pro_4_hyd_alph | 3.70e-03 | 16 | 107 | 2 | IPR006620 | |
| Domain | VWA | 4.07e-03 | 56 | 107 | 3 | PF00092 | |
| Domain | ARM-like | 4.62e-03 | 270 | 107 | 6 | IPR011989 | |
| Domain | 2OG-FeII_Oxy | 5.22e-03 | 19 | 107 | 2 | PF03171 | |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | FAT4 ITGA11 COL12A1 PLOD3 COL15A1 COPA SSR1 PTGFRN SIL1 ERG28 SLC12A2 PTPRJ PTPRK CGREF1 TTI1 TMEM109 PLOD2 | 5.15e-07 | 1201 | 116 | 17 | 35696571 |
| Pubmed | 1.10e-05 | 2 | 116 | 2 | 34788619 | ||
| Pubmed | Sidekick-1 is upregulated in glomeruli in HIV-associated nephropathy. | 1.10e-05 | 2 | 116 | 2 | 15213259 | |
| Pubmed | Definition of the critical domains required for homophilic targeting of mouse sidekick molecules. | 1.10e-05 | 2 | 116 | 2 | 15703275 | |
| Pubmed | 1.10e-05 | 2 | 116 | 2 | 30150416 | ||
| Pubmed | 1.10e-05 | 2 | 116 | 2 | 37828581 | ||
| Pubmed | 1.10e-05 | 2 | 116 | 2 | 11334715 | ||
| Pubmed | 1.10e-05 | 2 | 116 | 2 | 21233283 | ||
| Pubmed | Sidekicks: synaptic adhesion molecules that promote lamina-specific connectivity in the retina. | 1.10e-05 | 2 | 116 | 2 | 12230981 | |
| Pubmed | Molecular basis of sidekick-mediated cell-cell adhesion and specificity. | 1.10e-05 | 2 | 116 | 2 | 27644106 | |
| Pubmed | 2.80e-05 | 175 | 116 | 6 | 28071719 | ||
| Pubmed | 3.30e-05 | 3 | 116 | 2 | 20923779 | ||
| Pubmed | 3.30e-05 | 3 | 116 | 2 | 30926667 | ||
| Pubmed | 3.30e-05 | 3 | 116 | 2 | 10429951 | ||
| Pubmed | 3.30e-05 | 3 | 116 | 2 | 11896059 | ||
| Pubmed | 3.30e-05 | 3 | 116 | 2 | 11956192 | ||
| Pubmed | 3.30e-05 | 3 | 116 | 2 | 30478191 | ||
| Pubmed | Lysyl hydroxylase 3 is a multifunctional protein possessing collagen glucosyltransferase activity. | 3.30e-05 | 3 | 116 | 2 | 10934207 | |
| Pubmed | 3.30e-05 | 3 | 116 | 2 | 9582318 | ||
| Pubmed | 3.30e-05 | 3 | 116 | 2 | 16996725 | ||
| Pubmed | The genes encoding mouse lysyl hydroxylase isoforms map to chromosomes 4,5, and 9. | 3.30e-05 | 3 | 116 | 2 | 11130984 | |
| Pubmed | 3.30e-05 | 3 | 116 | 2 | 27255754 | ||
| Pubmed | 3.30e-05 | 3 | 116 | 2 | 31446433 | ||
| Pubmed | Glycosylation catalyzed by lysyl hydroxylase 3 is essential for basement membranes. | 6.59e-05 | 4 | 116 | 2 | 16467571 | |
| Pubmed | 6.59e-05 | 4 | 116 | 2 | 7838537 | ||
| Pubmed | Deadenylase-dependent mRNA decay of GDF15 and FGF21 orchestrates food intake and energy expenditure. | 6.59e-05 | 4 | 116 | 2 | 35385705 | |
| Pubmed | PLODs are overexpressed in ovarian cancer and are associated with gap junctions via connexin 43. | 6.59e-05 | 4 | 116 | 2 | 33483598 | |
| Pubmed | 6.59e-05 | 4 | 116 | 2 | 30106150 | ||
| Pubmed | Characterization of the Extracellular Matrix of Normal and Diseased Tissues Using Proteomics. | 9.29e-05 | 135 | 116 | 5 | 28675934 | |
| Pubmed | 1.10e-04 | 5 | 116 | 2 | 24108125 | ||
| Pubmed | The cell adhesion molecule Sdk1 shapes assembly of a retinal circuit that detects localized edges. | 1.10e-04 | 5 | 116 | 2 | 34545809 | |
| Pubmed | 1.10e-04 | 5 | 116 | 2 | 22977175 | ||
| Pubmed | 1.10e-04 | 5 | 116 | 2 | 35390160 | ||
| Pubmed | COL12A1 PLOD3 DRG2 COPA VPS33A SSR1 TRIP12 TTK CNOT6 GSTP1 CSTF1 TMEM109 PLOD2 CPSF3 | 1.10e-04 | 1297 | 116 | 14 | 33545068 | |
| Pubmed | Reporter-nanobody fusions (RANbodies) as versatile, small, sensitive immunohistochemical reagents. | 1.64e-04 | 6 | 116 | 2 | 29440485 | |
| Pubmed | 1.64e-04 | 6 | 116 | 2 | 14550773 | ||
| Pubmed | Differential expression of Slitrk family members in the mouse nervous system. | 1.64e-04 | 6 | 116 | 2 | 19924824 | |
| Pubmed | 1.64e-04 | 6 | 116 | 2 | 14557068 | ||
| Pubmed | 1.64e-04 | 6 | 116 | 2 | 30687002 | ||
| Pubmed | 1.64e-04 | 6 | 116 | 2 | 31924127 | ||
| Pubmed | 1.67e-04 | 32 | 116 | 3 | 23750785 | ||
| Pubmed | Mesenchyme-derived vertebrate lonesome kinase controls lung organogenesis by altering the matrisome. | 1.67e-04 | 32 | 116 | 3 | 36920550 | |
| Pubmed | 2.22e-04 | 613 | 116 | 9 | 22268729 | ||
| Pubmed | Human glutathione S-transferase P1-1 interacts with TRAF2 and regulates TRAF2-ASK1 signals. | 2.29e-04 | 7 | 116 | 2 | 16636664 | |
| Pubmed | Complex protein interactions within the human polyadenylation machinery identify a novel component. | 2.29e-04 | 7 | 116 | 2 | 10669729 | |
| Pubmed | 2.29e-04 | 7 | 116 | 2 | 17324935 | ||
| Pubmed | Capturing novel mouse genes encoding chromosomal and other nuclear proteins. | 2.29e-04 | 7 | 116 | 2 | 9701556 | |
| Pubmed | Premature aggregation of type IV collagen and early lethality in lysyl hydroxylase 3 null mice. | 2.29e-04 | 7 | 116 | 2 | 15377789 | |
| Pubmed | 2.51e-04 | 167 | 116 | 5 | 22159717 | ||
| Pubmed | 2.56e-04 | 371 | 116 | 7 | 15747579 | ||
| Pubmed | A neurogenomics approach to gene expression analysis in the developing brain. | 2.72e-04 | 170 | 116 | 5 | 15582152 | |
| Pubmed | 3.05e-04 | 8 | 116 | 2 | 22905720 | ||
| Pubmed | 3.05e-04 | 8 | 116 | 2 | 7590244 | ||
| Pubmed | 3.91e-04 | 9 | 116 | 2 | 21078877 | ||
| Pubmed | The C-terminal domain of RNA polymerase II couples mRNA processing to transcription. | 3.91e-04 | 9 | 116 | 2 | 9002523 | |
| Pubmed | 3.91e-04 | 9 | 116 | 2 | 21741365 | ||
| Pubmed | The cell proliferation antigen Ki-67 organises heterochromatin. | 4.66e-04 | 410 | 116 | 7 | 26949251 | |
| Pubmed | 4.88e-04 | 10 | 116 | 2 | 27618784 | ||
| Pubmed | 4.88e-04 | 10 | 116 | 2 | 16810323 | ||
| Pubmed | Large-scale structural analysis of the classical human protein tyrosine phosphatome. | 5.27e-04 | 47 | 116 | 3 | 19167335 | |
| Pubmed | 6.52e-04 | 117 | 116 | 4 | 17145500 | ||
| Pubmed | 7.12e-04 | 12 | 116 | 2 | 27782176 | ||
| Pubmed | 7.12e-04 | 12 | 116 | 2 | 17452450 | ||
| Pubmed | 7.12e-04 | 12 | 116 | 2 | 21705333 | ||
| Pubmed | Human Ccr4-Not complexes contain variable deadenylase subunits. | 7.12e-04 | 12 | 116 | 2 | 19558367 | |
| Pubmed | 7.12e-04 | 12 | 116 | 2 | 31320642 | ||
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | 7.37e-04 | 724 | 116 | 9 | 36232890 | |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | 7.66e-04 | 582 | 116 | 8 | 20467437 | |
| Pubmed | A germline-specific class of small RNAs binds mammalian Piwi proteins. | 8.05e-04 | 450 | 116 | 7 | 16751776 | |
| Pubmed | 8.40e-04 | 13 | 116 | 2 | 37070251 | ||
| Pubmed | Human metabolic individuality in biomedical and pharmaceutical research. | 9.28e-04 | 57 | 116 | 3 | 21886157 | |
| Pubmed | 9.66e-04 | 130 | 116 | 4 | 12421765 | ||
| Pubmed | 9.78e-04 | 14 | 116 | 2 | 34026442 | ||
| Pubmed | GW182 proteins directly recruit cytoplasmic deadenylase complexes to miRNA targets. | 1.13e-03 | 15 | 116 | 2 | 21981923 | |
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | PDE3B COPA SSR1 INTS8 TRIP12 PTGFRN SLC12A2 PTPRK TMEM109 PLOD2 | 1.25e-03 | 942 | 116 | 10 | 31073040 |
| Pubmed | Genetic predictors of fibrin D-dimer levels in healthy adults. | 1.28e-03 | 16 | 116 | 2 | 21502573 | |
| Pubmed | 1.28e-03 | 16 | 116 | 2 | 18308476 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | PDE3B CDH26 RPS6KA2 AGPAT3 SLITRK3 INTS8 CDC42EP3 SIL1 PTPRJ ANKAR TNK2 CFAP69 PDZD2 | 1.42e-03 | 1489 | 116 | 13 | 28611215 |
| Pubmed | Protein tyrosine phosphatases expression during development of mouse superior colliculus. | 1.45e-03 | 17 | 116 | 2 | 19727691 | |
| Pubmed | Fetal inhibition of inflammation improves disease phenotypes in harlequin ichthyosis. | 1.45e-03 | 17 | 116 | 2 | 25209981 | |
| Pubmed | PLOD3 IMPDH1 NT5E SSR1 INTS8 CNOT6 GREB1L LENG8 CNOT6L SLC12A2 CGREF1 CSTF1 DNMBP | 1.49e-03 | 1497 | 116 | 13 | 31527615 | |
| Pubmed | Quantitative Proteomics Links the LRRC59 Interactome to mRNA Translation on the ER Membrane. | 1.66e-03 | 375 | 116 | 6 | 32788342 | |
| Pubmed | A Compendium of RNA-Binding Proteins that Regulate MicroRNA Biogenesis. | 1.66e-03 | 254 | 116 | 5 | 28431233 | |
| Pubmed | 1.66e-03 | 814 | 116 | 9 | 23251661 | ||
| Pubmed | 1.71e-03 | 513 | 116 | 7 | 25798074 | ||
| Pubmed | 1.76e-03 | 153 | 116 | 4 | 25037231 | ||
| Pubmed | USP7 Cooperates with NOTCH1 to Drive the Oncogenic Transcriptional Program in T-Cell Leukemia. | 1.90e-03 | 73 | 116 | 3 | 30224337 | |
| Pubmed | 1.93e-03 | 263 | 116 | 5 | 34702444 | ||
| Pubmed | Gene-trap mutagenesis using Mol/MSM-1 embryonic stem cells from MSM/Ms mice. | 1.97e-03 | 74 | 116 | 3 | 23604909 | |
| Pubmed | 2.01e-03 | 20 | 116 | 2 | 21072184 | ||
| Pubmed | RNF219 attenuates global mRNA decay through inhibition of CCR4-NOT complex-mediated deadenylation. | 2.01e-03 | 20 | 116 | 2 | 34887419 | |
| Pubmed | Dysfunctional ryanodine receptor and cardiac hypertrophy: role of signaling molecules. | 2.01e-03 | 20 | 116 | 2 | 21421818 | |
| Pubmed | 2.02e-03 | 390 | 116 | 6 | 17643375 | ||
| Pubmed | SDK2 SSR1 ANO10 TTK DNTTIP2 SIL1 SLC12A2 CELF1 CSTF1 TMEM109 | 2.04e-03 | 1007 | 116 | 10 | 34597346 | |
| Pubmed | 2.12e-03 | 533 | 116 | 7 | 25544563 | ||
| Pubmed | 2.17e-03 | 162 | 116 | 4 | 25796446 | ||
| Pubmed | An Alternative Splicing Program for Mouse Craniofacial Development. | 2.22e-03 | 21 | 116 | 2 | 33013468 | |
| Pubmed | Interaction of antiproliferative protein Tob with the CCR4-NOT deadenylase complex. | 2.44e-03 | 22 | 116 | 2 | 18377426 | |
| Pubmed | 2.44e-03 | 22 | 116 | 2 | 38736483 | ||
| Pubmed | Global analysis of host-pathogen interactions that regulate early-stage HIV-1 replication. | 2.65e-03 | 283 | 116 | 5 | 18854154 | |
| GeneFamily | Fibronectin type III domain containing | 4.93e-05 | 160 | 74 | 6 | 555 | |
| GeneFamily | Collagens|Collagen proteoglycans | 1.64e-04 | 5 | 74 | 2 | 575 | |
| GeneFamily | CCR4-NOT transcription complex | 8.87e-04 | 11 | 74 | 2 | 1023 | |
| GeneFamily | Solute carriers | 1.15e-03 | 395 | 74 | 7 | 752 | |
| GeneFamily | ATP binding cassette subfamily A | 1.46e-03 | 14 | 74 | 2 | 805 | |
| GeneFamily | Protein tyrosine phosphatases, receptor type | 3.30e-03 | 21 | 74 | 2 | 813 | |
| CoexpressionAtlas | kidney_P0_CapMes_Crym_k-means-cluster#4_top-relative-expression-ranked_1000 | 1.31e-05 | 58 | 111 | 5 | gudmap_kidney_P0_CapMes_Crym_k4_1000 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.47e-07 | 184 | 116 | 7 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.47e-07 | 184 | 116 | 7 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.47e-07 | 184 | 116 | 7 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | COVID-19-kidney-Fibroblast-2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 8.07e-07 | 195 | 116 | 7 | 3d62ce1c696f47d4d7eb0c5bb0eec2c24b122bb2 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5-Exc_L5_RORB_LINC01202|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.99e-06 | 172 | 116 | 6 | 18bdf34e1b94dcb1daf00c533e3ce1a8d67fcc0e | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.02e-06 | 181 | 116 | 6 | 9d782ba5cf5a172cb4f447763fc50e5b13ef7dd9 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.28e-06 | 182 | 116 | 6 | 205d9ad1ea4b7adee8054496cdde46c9c401a19a | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_3|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.28e-06 | 182 | 116 | 6 | eb138aa1dca9373f1586600f258df06dcf56d81f | |
| ToppCell | (3)_Chondrocytes|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 1.12e-05 | 192 | 116 | 6 | 5d2b4830d025d3dbdf5623ce1c28d1036e1984a8 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.19e-05 | 194 | 116 | 6 | 011e14d9ed1393275f892060e7708ffadcd0767f | |
| ToppCell | Mesenchymal_cells-Fibro/Chondro_p.|World / Lineage and Cell class | 1.26e-05 | 196 | 116 | 6 | ddc168849e0e97005a111be004463bb72d433853 | |
| ToppCell | COVID-19-Fibroblasts-Intermediate_pathological_FB|COVID-19 / group, cell type (main and fine annotations) | 1.30e-05 | 197 | 116 | 6 | f1c8936986123a3151140c374fcd62d6705c530b | |
| ToppCell | Neuronal|World / cells hierarchy compared to all cells using T-Statistic | 1.41e-05 | 200 | 116 | 6 | 48d801219bc771d6c7e151dc88ca4c179988de85 | |
| ToppCell | Neuronal-Excitatory-eC(RORB)-eC_2-C1R-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.41e-05 | 200 | 116 | 6 | 891a80cbde575f81f3466217175f41e1d4f66d5e | |
| ToppCell | Neuronal-Excitatory-eC(RORB)-eC_2-C1R|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.41e-05 | 200 | 116 | 6 | c761d1742653a83e69e4c03d6e10e5e53f28bebb | |
| ToppCell | Neuronal-Excitatory-eC(RORB)-eC_2-C1R--L4-6|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.41e-05 | 200 | 116 | 6 | dcbc91ed3351bafd72cf71d7025cbbdc8361d9b9 | |
| ToppCell | Substantia_nigra-Endothelial-ENDOTHELIAL_TIP-Dcn_1|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 2.49e-05 | 132 | 116 | 5 | 893b7ec2a2d8a140cc98575d1beca1189f053e9a | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_2-AT1_Progenitor|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.90e-05 | 145 | 116 | 5 | 186b8bd8ac2d5c66cc29fdc2dd6751eddce3e8b8 | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L2/3_IT|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.30e-05 | 148 | 116 | 5 | d5cace5605bff2bb8248fadb51f2dad7539930ba | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|kidney / Disease (COVID-19 only), tissue and cell type | 6.05e-05 | 159 | 116 | 5 | 5335cbcdeaf2bbd0268bbfe0e45c8c0d288e640d | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Imm)|kidney / Disease (COVID-19 only), tissue and cell type | 6.81e-05 | 163 | 116 | 5 | 19c28ce16a588a7f4a035c32726f6ccd67702b5b | |
| ToppCell | Globus_pallidus-Endothelial-ENDOTHELIAL_TIP-Dcn_1|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 7.21e-05 | 165 | 116 | 5 | 570483b43ccb5831feec9337b4664814431d40b1 | |
| ToppCell | Globus_pallidus-Endothelial-ENDOTHELIAL_TIP|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 7.21e-05 | 165 | 116 | 5 | 2026a9a07f4d314cc05c167e491312b373468e46 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Degenerative_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.63e-05 | 167 | 116 | 5 | 3edb0570e583bb527165bcd8a4c25a042054043b | |
| ToppCell | COVID-19-Heart-CM_+_Macrophage|Heart / Disease (COVID-19 only), tissue and cell type | 8.30e-05 | 170 | 116 | 5 | 4232fe937909f93d3736988c707b8f95ce993398 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5-Exc_L5_RORB_LINC01202|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.30e-05 | 170 | 116 | 5 | 87cac555f16b6c2ef3d1b3a00f992d8bf2237b50 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(nasal)|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.30e-05 | 170 | 116 | 5 | 330b5fc8fde307eda9dcc7bc9053ea8a7e1f0f6d | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(nasal)-Club_(nasal)_L.0.2.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.30e-05 | 170 | 116 | 5 | 0c9d38e89b048166b879e6b4bdf7c5dfe8ab57c4 | |
| ToppCell | 343B-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_1|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 8.77e-05 | 172 | 116 | 5 | d65ffff3e341af34a043a0d802d7ba4b69de36e9 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.77e-05 | 172 | 116 | 5 | 41ddfb316429efef5f3fa0b0621ced383d9206f0 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.77e-05 | 172 | 116 | 5 | afa36501d48b1456c511fa0d5d326ec05bdc380f | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Myeloid-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.01e-05 | 173 | 116 | 5 | a664dbd7fb55b1c4309fa5f9425bc83924dac545 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5-Exc_L5-6_RORB_LINC00320|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.01e-05 | 173 | 116 | 5 | 4ec147479b359cce1975d57a50ee1437a0e1e663 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Myeloid-macrophage|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.01e-05 | 173 | 116 | 5 | 054f64462b648ba6b4b28b48c716dc01b2ddd790 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Myeloid|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.01e-05 | 173 | 116 | 5 | 9a8fec9a08bb61456a4ea43ae1316bd3e197a773 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.26e-05 | 174 | 116 | 5 | bc978a2148a0261a4f9d1ca5479b707e224566be | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2-Exc_L6_FEZF2_TBCC|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.26e-05 | 174 | 116 | 5 | 912a9e892b29d945666fc37c986009c97c668ac8 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.26e-05 | 174 | 116 | 5 | f1fe1f4216748a9562dd03bd48c70b23c7ff4d1d | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_FAM95C|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.51e-05 | 175 | 116 | 5 | 90e29945aa861082c94bb4f331161adc3a6ef899 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.77e-05 | 176 | 116 | 5 | e4b21fd6a5e0c5950f27c3e1868318e48330ae5e | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5-Exc_L5_RORB_LINC01202|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.00e-04 | 177 | 116 | 5 | b6476a91abd06b8271b4d0ad7431d24b44022b47 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.03e-04 | 178 | 116 | 5 | b169aa5eaa51730daaec69c6bc58126be1592a50 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_2-Inh_L3-6_PVALB_MFI2_(Chandelier_2)|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.03e-04 | 178 | 116 | 5 | c982a73955c9c193bcab21d60d453afcc09cd586 | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.06e-04 | 179 | 116 | 5 | a1ea8daa0fe8900f5a04b555c77fe8ebdaa3908d | |
| ToppCell | 10x5'v1-week_12-13-Lymphocytic_T-T_NK-CD8_T_cell|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.09e-04 | 180 | 116 | 5 | 5273aa2b939b5c640d708d6ca1812550dff5ec0f | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_IT_L5/L6_Car3_THEMIS|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.11e-04 | 181 | 116 | 5 | 13270b6ba6a9c8e5681c6f40000c643ce1d9344a | |
| ToppCell | COVID-19-T_cells-Tregs|COVID-19 / group, cell type (main and fine annotations) | 1.11e-04 | 181 | 116 | 5 | 534659cf754326c6a73c0daa30e9d610612a0292 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.11e-04 | 181 | 116 | 5 | b116c68393d8836bac080f81a8fcbeb52e0403e7 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 1.11e-04 | 181 | 116 | 5 | c80ffa2ded5975a88e9a1a7d333196f95237bf0a | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6-Exc_L6_THEMIS_LINC00343|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.14e-04 | 182 | 116 | 5 | cc6f9d606a4f8717dc44928ceec2a257636043fd | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.14e-04 | 182 | 116 | 5 | 35b2a5625323bf0917214d3b82fafc4a8f5e75ff | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.17e-04 | 183 | 116 | 5 | 65f2a5895d166189a095cf7ea9dda171f0419b08 | |
| ToppCell | normal_Lung-Fibroblasts-Myofibroblasts|normal_Lung / Location, Cell class and cell subclass | 1.20e-04 | 184 | 116 | 5 | 0b336489c10e8c3c957795dd845454f03404382b | |
| ToppCell | Mesenchymal_cells-Chondrocytes|World / Lineage and Cell class | 1.20e-04 | 184 | 116 | 5 | 1e03f9f08de5ad4d45388a95afad9f23ff0d0e28 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.20e-04 | 184 | 116 | 5 | 327ff3ac8d2fecdd5d242bdc34f0dfdb1c59a68b | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro2_(5)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.27e-04 | 186 | 116 | 5 | 7def03dd856b765bd3f493288641981c4f7fd26e | |
| ToppCell | droplet-Fat-SCAT-30m-Epithelial|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.30e-04 | 187 | 116 | 5 | 5fada3c5a58c1890029ccbfff2608b33f8cd2df7 | |
| ToppCell | droplet-Fat-SCAT-30m-Epithelial-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.30e-04 | 187 | 116 | 5 | 766e808138fc2cd623c2e6d57fcb5c7378da0e03 | |
| ToppCell | COVID-19-Fibroblasts-Airway_smooth_muscle|COVID-19 / group, cell type (main and fine annotations) | 1.30e-04 | 187 | 116 | 5 | 464a0c3b92b778911b5f9cd73642e09e3472063a | |
| ToppCell | droplet-Fat-SCAT-30m-Epithelial-epithelial_cell|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.30e-04 | 187 | 116 | 5 | f49d06600060deeb2fc1b1da5b93496535f20104 | |
| ToppCell | droplet-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.33e-04 | 188 | 116 | 5 | 6c6486cae9a8f2f8200598cb4bfd3fd513eb28a3 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.36e-04 | 189 | 116 | 5 | 1ecf9911ff82e0ca0f0c101b735d3b1f3b339d57 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.36e-04 | 189 | 116 | 5 | a75226616340045b581d08429d2e123e041dee55 | |
| ToppCell | NS-critical-d_07-13-Epithelial-FOXN4+|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.40e-04 | 190 | 116 | 5 | 7be0f2ff86ca8500a43e0d44e5e292530f9ba0bb | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.40e-04 | 190 | 116 | 5 | efb757f11c2809e66ddb48a5c84f5433f111cb7c | |
| ToppCell | 367C-Lymphocytic-NK_cells-NK_cell_B1|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.40e-04 | 190 | 116 | 5 | 2434b8ad2976eab7d9147012c28454ab29670709 | |
| ToppCell | NS-moderate-d_16-33-Epithelial-FOXN4+|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.40e-04 | 190 | 116 | 5 | 250ca4a605c1cccd77d23383e4fe6f91cf3609ba | |
| ToppCell | human_hepatoblastoma-Endothelial_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 1.40e-04 | 190 | 116 | 5 | 8d6ef93d69e96cd6921816d152bea3b0710cf147 | |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|LV / Chamber and Cluster_Paper | 1.43e-04 | 191 | 116 | 5 | 25f3eb34f4e70761e81e84c8a5829f216108cbc6 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.43e-04 | 191 | 116 | 5 | 04c4d454b57e29a8d1dcdeb4678ce71bdc29b77b | |
| ToppCell | Globus_pallidus-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Endothelial_Tip.Dcn.Col15a1_(Col15a1)-|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.47e-04 | 102 | 116 | 4 | 0bbc6344d0baee47326a16a89773bb5c68a7b040 | |
| ToppCell | Globus_pallidus-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Endothelial_Tip.Dcn.Col15a1_(Col15a1)|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.47e-04 | 102 | 116 | 4 | 11fbdb428824023603e9d4ee41e957ba84e7c29e | |
| ToppCell | Mesenchymal_cells-Ng2+_MSCs|World / Lineage and Cell class | 1.47e-04 | 192 | 116 | 5 | 0703b8ec6960ff975ee5a2737054db67cab016b5 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.50e-04 | 193 | 116 | 5 | 9f69edc97b868d23998abc98928a2e89a885ef8a | |
| ToppCell | 11.5-Airway-Mesenchymal-Cartilage|Airway / Age, Tissue, Lineage and Cell class | 1.50e-04 | 193 | 116 | 5 | d4779d92a4dd4b8b656383e6f4fce76d3bd70931 | |
| ToppCell | Children_(3_yrs)-Immune-monocyte-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.50e-04 | 193 | 116 | 5 | 58e1930a1d80ad3729ab9604ac8ebf7308232a3d | |
| ToppCell | Control-CD8+_T_naive|Control / Disease condition and Cell class | 1.50e-04 | 193 | 116 | 5 | 627d345baf1940218c61907305705298e473dbab | |
| ToppCell | human_hepatoblastoma-Tumor_cells|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells) | 1.50e-04 | 193 | 116 | 5 | 503a979328c68b096680b71359a26f02fafdff35 | |
| ToppCell | Mesenchymal-matrix_fibroblast_1_cell|World / Lineage, Cell type, age group and donor | 1.50e-04 | 193 | 116 | 5 | acad568621ed677031797b8c2e34dafea798d681 | |
| ToppCell | moderate-Epithelial-FOXN4+|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.54e-04 | 194 | 116 | 5 | 5dffa578149104dda33774361e9e77b227b5f1ce | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.54e-04 | 194 | 116 | 5 | 71d3c7448b1734de54187f902f65649f9283bd4c | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_osteo-stroma-osteoblast|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.54e-04 | 194 | 116 | 5 | 292ce9021678534c9eedb367b9772a9d976208a8 | |
| ToppCell | LA-14._Fibroblast_III|World / Chamber and Cluster_Paper | 1.54e-04 | 194 | 116 | 5 | 803fa83ceada17c38ca9f933b888f7e7b0b90761 | |
| ToppCell | Mesenchymal_cells-Fibro/Chondro_p.|Mesenchymal_cells / Lineage and Cell class | 1.58e-04 | 195 | 116 | 5 | b95a631d54c6cf85e48e1e638703206aaaebc073 | |
| ToppCell | medial-Hematologic-CD8+_Memory/Effector_T-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.62e-04 | 196 | 116 | 5 | 252e15a4ea54d872c5b910711941dcdf359c0492 | |
| ToppCell | medial-Hematologic-CD8+_Memory/Effector_T|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.62e-04 | 196 | 116 | 5 | caef28955269f4f6fb323a74b6b73cff8db11272 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.62e-04 | 196 | 116 | 5 | 676c56b44ac29f7baecb62f49bb8597cc74c0a88 | |
| ToppCell | medial-2-Hematologic-CD8+_Memory/Effector_T|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.62e-04 | 196 | 116 | 5 | e401d1683a13f2636e8fc0e22428a6a3653a1521 | |
| ToppCell | Children_(3_yrs)-Immune-monocyte|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.62e-04 | 196 | 116 | 5 | cacd69be72e6167814f7adea7c5fa114f3103bbb | |
| ToppCell | 10x5'v1-week_17-19-Mesenchymal_osteo-stroma-osteoblast|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.62e-04 | 196 | 116 | 5 | d5ed41fa111750e6b363c04cccc40a47dd774852 | |
| ToppCell | (2)_Fibroblasts-(23)_Fibro-4|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 1.66e-04 | 197 | 116 | 5 | a183919023a4aca90a06be0e5e89c817b38c5574 | |
| ToppCell | IPF-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 1.66e-04 | 197 | 116 | 5 | f304d42fc4936fe20996e07c8dccc698a6e5e5ef | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.69e-04 | 198 | 116 | 5 | c01091ef18e096d792ea2a7a715764a5b215355f | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_neuro-secretory-Neuroendocrine|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.69e-04 | 198 | 116 | 5 | 8f25e8dff42bad8e779ca618bdb1cb1610667962 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_neuro-secretory|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.69e-04 | 198 | 116 | 5 | e3e0aa3ef20b2370f5b133048510677aaa562dfa | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_basal-Suprabasal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.69e-04 | 198 | 116 | 5 | 19d8ff3a4f911b13ecc34844202925475ad4d2ab | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.69e-04 | 198 | 116 | 5 | 0ff30edfd3c133a42e8cb96e1631a1143215f808 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.69e-04 | 198 | 116 | 5 | 5374b0e98d669f36a0571d3c006c7bd5e3c8e87f | |
| ToppCell | Fetal_29-31_weeks|World / Lineage, Cell type, age group and donor | 1.73e-04 | 199 | 116 | 5 | 5b9d355795dd03a22f0961dfd143425c367a4654 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_basal-Basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.73e-04 | 199 | 116 | 5 | 94a7867e800df352731796de8c24cba133c29622 | |
| Disease | transmembrane protein 132A measurement | 8.07e-05 | 4 | 109 | 2 | EFO_0802150 | |
| Disease | X-21471 measurement | 2.01e-04 | 6 | 109 | 2 | EFO_0800818 | |
| Disease | glycocholenate sulfate measurement | 2.01e-04 | 6 | 109 | 2 | EFO_0800276 | |
| Disease | visual epilepsy (implicated_via_orthology) | 2.70e-04 | 34 | 109 | 3 | DOID:11832 (implicated_via_orthology) | |
| Disease | heart disease (implicated_via_orthology) | 3.76e-04 | 38 | 109 | 3 | DOID:114 (implicated_via_orthology) | |
| Disease | X-21467 measurement | 4.79e-04 | 9 | 109 | 2 | EFO_0020007 | |
| Disease | obsolete_9,10-dihome measurement | 5.97e-04 | 10 | 109 | 2 | EFO_0021572 | |
| Disease | triacylglycerol 54:4 measurement | 6.63e-04 | 46 | 109 | 3 | EFO_0010422 | |
| Disease | response to statin, myopathy | 7.28e-04 | 11 | 109 | 2 | EFO_0004145, GO_0036273 | |
| Disease | Hepatic fibrosis | 7.98e-04 | 49 | 109 | 3 | HP_0001395 | |
| Disease | X-21470 measurement | 1.20e-03 | 14 | 109 | 2 | EFO_0800817 | |
| Disease | blood osmolality measurement | 1.31e-03 | 58 | 109 | 3 | EFO_0007967 | |
| Disease | Chromosome Aberrations | 1.57e-03 | 16 | 109 | 2 | C0008625 | |
| Disease | neutrophil collagenase measurement | 1.57e-03 | 16 | 109 | 2 | EFO_0008248 | |
| Disease | lysosomal storage disease (implicated_via_orthology) | 1.57e-03 | 16 | 109 | 2 | DOID:3211 (implicated_via_orthology) | |
| Disease | Autosome Abnormalities | 1.57e-03 | 16 | 109 | 2 | C0004403 | |
| Disease | Schizophrenia | ABCA13 RIMS3 MCHR2 HTR3E CDC42EP3 ITIH1 GSTP1 SLC12A2 TLR2 CNTNAP2 | 1.62e-03 | 883 | 109 | 10 | C0036341 |
| Disease | biological sex | 1.67e-03 | 230 | 109 | 5 | PATO_0000047 | |
| Disease | grip strength measurement | 1.94e-03 | 350 | 109 | 6 | EFO_0006941 | |
| Disease | Cannabis use, age at onset | 2.22e-03 | 19 | 109 | 2 | EFO_0004847, EFO_0007585 | |
| Disease | lung disease (is_implicated_in) | 2.98e-03 | 22 | 109 | 2 | DOID:850 (is_implicated_in) | |
| Disease | Epilepsy, Cryptogenic | 3.51e-03 | 82 | 109 | 3 | C0086237 | |
| Disease | Awakening Epilepsy | 3.51e-03 | 82 | 109 | 3 | C0751111 | |
| Disease | Aura | 3.51e-03 | 82 | 109 | 3 | C0236018 | |
| Disease | short-term memory | 3.64e-03 | 83 | 109 | 3 | EFO_0004335 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SGGNPILFELEKNLY | 66 | P41214 | |
| GPFNLLCYQLQKLTG | 521 | Q9UKF6 | |
| GNRVPFKITLLLGYN | 276 | A5X5Y0 | |
| NVVQLLPGVGTFYNL | 181 | Q13790 | |
| NLAGLNTLGPQYLAL | 216 | Q92879 | |
| GNILPKTNGFILFLY | 1136 | Q86UK0 | |
| EYTLLNPLGNKFSIG | 2086 | Q6V0I7 | |
| PGIQFKGQHLNLLEY | 4976 | Q86UQ4 | |
| LLLLLVYLTQPGNGN | 16 | Q9H2A7 | |
| NYINLGSFLIKPVQR | 911 | Q6XZF7 | |
| FQPGQEQLGLLQSYL | 41 | Q99674 | |
| ISFLQGNYELLPGNQ | 56 | Q9UKI2 | |
| YILQAILQPGKKIQG | 66 | P0CE67 | |
| LRFPQLYKITQNGEG | 941 | Q9NTI2 | |
| QYLKVEQLFGLGLRP | 991 | Q07912 | |
| LPGNIFRGLVSLQYL | 146 | Q86UN3 | |
| INLGLPFGKVTNYIL | 536 | Q5T481 | |
| LGLPVGNYVQLLAKI | 46 | Q6BCY4 | |
| PAFLLQSNPYVKLGQ | 681 | Q75QN2 | |
| GGAQLLFRPLLNKYE | 46 | Q9NW15 | |
| KYNGIPSLINLLNLN | 821 | Q7Z5J8 | |
| GPTKLQLNYLGNYVP | 256 | O60568 | |
| GLKPGVQYNINPYLL | 261 | Q12913 | |
| NQSIIIGGLFPGTKY | 501 | Q12913 | |
| GFQPQTYLVQGVKAL | 421 | Q6ZMT4 | |
| YVLVGKLDFPNQGSL | 176 | A8MXT2 | |
| QQLQGFYSQVAKPLL | 466 | P19827 | |
| GNTLYGLSVLLKNPE | 226 | Q6ZP29 | |
| NDLGNKGYLVFGLIL | 266 | Q96N19 | |
| ALDINKAGILYGIPQ | 291 | Q8N3X6 | |
| GLFKNSNENLLPGYL | 421 | P83111 | |
| QLKSLYAENLPGNVG | 646 | Q96PV6 | |
| NLTGKAPNILLYVGS | 156 | P50747 | |
| LANGQGIYSVKPLLD | 2271 | O15018 | |
| YLNGPFNSNLLTIPK | 476 | Q13370 | |
| KLYTGKPNLVNGLQA | 36 | Q9UKR5 | |
| NVVYILGGSQLFPIK | 336 | Q8IXQ5 | |
| INILKKFYIGPGQIQ | 186 | Q9UKX5 | |
| KLGLQYRFEIILGNP | 981 | Q9C091 | |
| GIFKGLLNLRNLYLQ | 126 | Q7Z2Q7 | |
| AINGNGPTKILLNYF | 251 | O00469 | |
| NLNQNPRTLLPKFYG | 161 | A2A3N6 | |
| GSIQKFVPYLIAGIQ | 451 | P20839 | |
| VKNLYQLSNLGIPGV | 251 | Q14112 | |
| INPFLYILLSGNFQK | 301 | Q969V1 | |
| YILLSGNFQKRLPQI | 306 | Q969V1 | |
| GLYFIKPLKANQQFL | 191 | P02679 | |
| SLLQAVANLPYKGGN | 1261 | Q99715 | |
| QVGVIQFGPYKQLFL | 946 | P53621 | |
| LAYKQPGGITNQFLL | 351 | Q495W5 | |
| GQLPKFQDGDLTLYQ | 51 | P09211 | |
| PLYGGDQTQKILALF | 56 | Q9Y6X4 | |
| SGPLGLYRNNLLQQF | 306 | Q92839 | |
| KTDLPQYIIGQLGLA | 311 | O60307 | |
| NYLVPLFIGDKQGLS | 571 | Q8IXH8 | |
| VLSLNLGSNQLGPIY | 246 | Q9UHC6 | |
| LGLTLYLTCNPQLGK | 61 | P0C5K7 | |
| GYISIANGLINEIKP | 26 | Q05048 | |
| PRKLQSGLGYNVLLF | 571 | A5D8W1 | |
| YSLPIVNLKGQVLFN | 1271 | P39059 | |
| ALQKGLAPALLYQFL | 61 | Q3KQZ1 | |
| PEQDQNGLILGYKIL | 1301 | Q7Z5N4 | |
| QQNISFLLGYSIPVG | 221 | Q8IY34 | |
| SPQFINGINQGYKLI | 816 | Q58EX2 | |
| LLGNILKIIYNNLGI | 3276 | Q92736 | |
| GLKGNPLTQDILNLY | 126 | Q9ULM6 | |
| IKVNGSLGLELQQPY | 1471 | P98161 | |
| LLYSQKGLNPGTLNI | 111 | Q15262 | |
| LGVGPTYLLIQLNAN | 301 | Q15262 | |
| IVPQKGNLLIYTEFG | 156 | Q93099 | |
| LYLLQQIGPNSFLIG | 316 | Q13233 | |
| ALGKQPVSFYQLLLQ | 201 | Q8TC99 | |
| LNAFKYPLLIGVGLS | 826 | Q9P2B2 | |
| ILAQLNAKYGSGVLP | 616 | Q92541 | |
| LGPGLAVLCKNYLFQ | 216 | Q6NUJ1 | |
| GRPFGLVINLNYKDL | 166 | P43307 | |
| RGNQLQTLPYVGFLE | 191 | Q9H5Y7 | |
| NIYPLSFLLNLGRKQ | 411 | Q8IVB4 | |
| GRLCGKIQTLFLQYP | 731 | A0AVI2 | |
| IPKGELNGFYALQIN | 76 | Q9H9A7 | |
| LYQQALLFDEGPQGK | 221 | Q9UJD0 | |
| NPILYGFLNNGIKAD | 421 | Q15761 | |
| AFINLPNLKSLFLNG | 451 | O94933 | |
| YTPLNQLKGGTIVNV | 11 | Q9NUX5 | |
| PYAQRQFLKLGGLQV | 301 | Q9H173 | |
| GFQNLPLNIYIVVFG | 16 | Q9Y225 | |
| YKGANIQLLDLPGII | 106 | P55039 | |
| QYGQPSSKANILLGV | 366 | Q9Y6L6 | |
| IAQLLLLPYIKGGNS | 746 | P63128 | |
| YDLKPGNILLVNGTA | 591 | Q86UE8 | |
| EVYKVILPNFLANGG | 491 | P21589 | |
| IIQDTQFRGYLLPKG | 26 | Q6ZSU1 | |
| GLKGNPLSQDILNLY | 131 | Q96LI5 | |
| PGLSIKQLGGLYINF | 566 | Q5QJE6 | |
| KGLPQKTLLGQGYQA | 226 | Q8IU68 | |
| IPKTLGNLYNSLGFV | 781 | Q7Z2Z1 | |
| GNLYNSLGFVIPQKL | 786 | Q7Z2Z1 | |
| NFRGNKNPSLLGILY | 231 | Q9NRZ7 | |
| LYQLNPGALGVNLVV | 31 | Q8NE28 | |
| GKNNEPLRGYILTFL | 646 | P55011 | |
| LFILLGPLGKGQQYH | 371 | Q6U841 | |
| VQYPGEGLQLLLKAT | 56 | A0A087WT02 | |
| SGNLKEGLQYPQSLN | 101 | Q2M238 | |
| GFLYLNIGLQNGVLL | 661 | Q15393 | |
| ALAPGGLQQILNFIY | 61 | Q9UFB7 | |
| YLAQGLKLSPGQVQT | 116 | Q9BVC6 | |
| YVLGQLVGLNSPNSI | 811 | P33981 | |
| KLQYILAQIGFSVGL | 66 | Q9H1V8 | |
| VNLAQGYLQLKGLSL | 91 | Q5W5X9 | |
| TLQALYGTIPQIFGK | 181 | Q96AX1 | |
| LYAELLGKPRGFQQQ | 1726 | Q9BXT5 | |
| LYLDGNQFTLVPGQL | 766 | O75093 | |
| GTKYIQNLQGLFALP | 1666 | Q14669 | |
| LTFLNLLGNPYKTLG | 126 | O60603 | |
| YPGQAQQKLVGLEKL | 681 | Q6ZQQ6 | |
| GQLINLFYIPSGTKQ | 61 | A0A0B4J277 | |
| VQSPGQGLQLLLKYF | 56 | A0A0A6YYJ7 | |
| SLYINNPLLIGGRKF | 181 | O95922 | |
| GYLKLLGPKINFVLN | 406 | O43156 | |
| NYGNLVSLGLAIFKP | 36 | B4DX44 | |
| PSQFELLKVLGQGSY | 56 | Q15349 |